PCM
BHVN

Pentwater Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Pentwater Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,163,000
Closed -$176M – 132
2022
Q3 		$176M Sell
1,163,000
-267,000
-19% -$40.4M 1.97% 9
2022
Q2 		$208M Buy
+1,430,000
New +$208M 2.45% 9